Menu

• Ask a Health Expert about CARBON MONOXIDE DIFFUSING CAPACITY DECREASED
• Post Your Side Effect related to CARBON MONOXIDE DIFFUSING CAPACITY DECREASED
• CARBON MONOXIDE DIFFUSING CAPACITY DECREASED and FDA Warnings
• CARBON MONOXIDE DIFFUSING CAPACITY DECREASED in Patients Wiki
• Report CARBON MONOXIDE DIFFUSING CAPACITY DECREASED in Drug Side Effect Survey

CARBON MONOXIDE DIFFUSING CAPACITY DECREASED side effect

What is CARBON MONOXIDE DIFFUSING CAPACITY DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Velcade Side Effects Report #5507588-8
Physician from UNITED STATES reported VELCADE problem on Oct 24, 2007. Male patient, 73 years of age, weighting 207.7 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: carbon monoxide diffusing capacity decreased, febrile neutropenia, forced expiratory volume abnormal, hypoxia, infection, pulmonary toxicity, . VELCADE dosage: 2.75 MG, IV BOLUS, 1.47 MG, INTRAVENOUS. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN RDF, DEXAMETHASONE, CYTARABINE, METHOTREXATE. Patient recovered.

Aerx Side Effects Report #5697574-X
AERX SOLUTION problem was reported by a Physician from FRANCE on Mar 28, 2008. Female patient, weighting 154.3 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with AERX SOLUTION. After drug was administered, patient experienced the following problems/side effects: carbon monoxide diffusing capacity decreased, . AERX SOLUTION dosage: unknown. During the same period patient was treated with INSULIN DETEMIR FLEXPEN, KENZEN, LEVOTHYROXINE, CELECTOL, LASILIX, OGAST, ZANIDIP, HYPERIUM. Patient recovered.

Aerx Side Effects Report #5721378-2
Physician from FRANCE reported AERX SOLUTION problem on Apr 17, 2008. Female patient, weighting 154.3 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with AERX SOLUTION. After drug was administered, patient experienced the following problems/side effects: carbon monoxide diffusing capacity decreased, . AERX SOLUTION dosage: unknown. During the same period patient was treated with INSULIN DETEMIR FLEXPEN, KENZEN, LEVOTHYROXINE, CELECTOL, LASILIX, OGAST, ZANIDIP, HYPERIUM. Patient recovered.

Certican Side Effects Report #5404799-7
CERTICAN problem was reported by a Physician from GERMANY on July 23, 2007. Male patient was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: alveolitis, carbon monoxide diffusing capacity decreased, cough, dyspnoea, interstitial lung disease, lung infection, respiratory failure, . CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with MYFORTIC, PREDNISONE. Patient was hospitalized. Patient recovered.


Carboplatin Side Effects Report #5390900-0
Physician from UNITED STATES reported CARBOPLATIN problem on July 02, 2007. Male patient, 68 years of age, was diagnosed with bladder cancer stage iv and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: atelectasis, carbon monoxide diffusing capacity decreased, cryptogenic organising pneumonia, febrile neutropenia, haemoptysis, hypoxia, leukocytosis, sputum abnormal, . CARBOPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5394965-1
EXJADE problem was reported by a Physician from ARGENTINA on July 17, 2007. Female patient, 14 years of age, was diagnosed with pulmonary haemosiderosis and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: acute tonsillitis, carbon monoxide diffusing capacity decreased, encephalitis viral, life support, pneumonia, pseudomonas infection, pulmonary haemosiderosis, . EXJADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5390900-0
Physician from UNITED STATES reported CARBOPLATIN problem on July 02, 2007. Male patient, 68 years of age, was diagnosed with bladder cancer stage iv and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: atelectasis, carbon monoxide diffusing capacity decreased, cryptogenic organising pneumonia, febrile neutropenia, haemoptysis, hypoxia, leukocytosis, sputum abnormal, . CARBOPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5394965-1
EXJADE problem was reported by a Physician from ARGENTINA on July 17, 2007. Female patient, 14 years of age, was diagnosed with pulmonary haemosiderosis and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: acute tonsillitis, carbon monoxide diffusing capacity decreased, encephalitis viral, life support, pneumonia, pseudomonas infection, pulmonary haemosiderosis, . EXJADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient was hospitalized. Patient recovered.

Certican Side Effects Report #5370034-1
Physician from GERMANY reported CERTICAN problem on June 12, 2007. Male patient was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: alveolitis, carbon monoxide diffusing capacity decreased, cough, dyspnoea, interstitial lung disease, respiratory failure, superinfection, . CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with MYFORTIC, PREDNISONE. Patient was hospitalized. Patient recovered.


Certican Side Effects Report #5370384-9
CERTICAN problem was reported by a Physician from GERMANY on June 12, 2007. Male patient was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: alveolitis, carbon monoxide diffusing capacity decreased, cough, dyspnoea, interstitial lung disease, respiratory failure, superinfection, . CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with MYFORTIC, PREDNISONE. Patient was hospitalized. Patient recovered.

Enbrel Side Effects Report #5268191-0
Physician from FRANCE reported ENBREL problem on Mar 05, 2007. Male patient, 44 years of age, was diagnosed with ankylosing spondylitis, asthma, migraine and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, carbon monoxide diffusing capacity decreased, dyspnoea, lung disorder, obstructive airways disorder, oedema peripheral, vital capacity decreased, weight increased, . ENBREL dosage: unknown. During the same period patient was treated with DEPAKENE, VENTOLIN, OXYCONTIN, PERISTALTINE, TRANSIPEG, TAHOR, AVLOCARDYL, NEXIUM. Patient recovered.